Accolade, Inc. Provides Earnings Guidance for the Third Quarter Ending November 30, 2021 and Fiscal Year Ending February 28, 2022
October 07, 2021 at 04:05 pm EDT
Share
Accolade, Inc. provided earnings guidance for the third quarter ending November 30, 2021 and fiscal year ending February 28, 2022. For the quarter, the company expects revenue to be between $74.5 million and $76.5 million, which includes approximately $2.5 million of performance guarantee revenue that is expected to be recognized in the fiscal third quarter that was previously expected to be recognized in the fiscal fourth quarter.
For the year, the company expects revenue to be between $303 million and $307 million.
Accolade, Inc. provides personalized, technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. Its customers are primarily employers that deploy Accolade solutions in order to provide employees and their families with a single place to turn for their health, healthcare, and benefits needs. It also offers medical opinion services to commercial customers and virtual primary care and mental health support. Its platform, True Health Engine, combines open, cloud-based intelligent technology with multimodal support from a team of empathetic and knowledgeable Accolade Health Assistants and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, womenâs health specialists, case management specialists, expert medical opinion providers, and virtual primary care physicians. Its offerings include Accolade Expert MD, Accolade Care, Plus and Connect and Accolade One.
ACCOLADE, INC. 
